Nike replaces CFO Matthew Friend with Pfizer's David Denton, effective Aug 17

Filed June 23, 2026 · Period ending June 16, 2026 · ~1 min read

Key Changes

• high

  David Denton joins as CFO Aug 17 from Pfizer, bringing 30+ years finance experience including CFO roles at Pfizer (2022-present) and Lowe's (2018-2022); receives $1.45M base salary, $11.5M annual LTI target, plus $7.25M cash and $4M performance award.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• high

  CFO Matthew Friend steps down Aug 17, transitions to advisor role through Sep 4 separation; departure not due to disagreement with management or board; receives $2M transition benefit plus severance.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• medium

  Q4 FY2026 results (due June 30) will include unexpected one-time benefit from tariff refunds not in prior guidance; excluding this benefit, results expected to align with previous guidance.

  Exhibit 99.1 verify on EDGAR →